Study Links Vaping to Disease-Causing Genetic Changes

Industry Insight by Vaping Post
Jun.02.2022
A recent study published in Scientific Reports, has linked vaping to changes in mitochondrial and immune response genes.

A novel role for vaping in mitochondrial gene dysregulation and inflammation fundamental to disease development,” the current study was conducted by a team of researchers at the Keck School of Medicine of USC. To conduct their analysis the researchers recruited a diverse group of 82 healthy adults and separated them into three groups: current vapers, with and without a prior history of smoking; people who exclusively smoke cigarettes; and a control group of never-smokers and never-vapers. 

 

They then conducted a number of biochemical tests to detect any changes in gene regulation and comprehensive interview so as to be able to link test results with their consumption behaviour. 

An article on News-Medical highlighted that on analysing the compiled data, the researchers found significant dysregulation of immune response genes in both vapers and smokers. However, the finding that was mostly emphasized on, is one based on computational modeling, suggesting “that ‘current’ vaping, but not ‘past’ smoking, is significantly associated with gene dysregulation in vapers.”

On the other hand, other tests indicated that smoking causes more genetic damage. “Comparative analysis of the gene networks and canonical pathways dysregulated in vapers and smokers showed strikingly similar patterns in the two groups, although the extent of transcriptomic changes was more pronounced in smokers than vapers. Of significance is the preferential targeting of mitochondrial genes in both vapers and smokers, concurrent with impaired functional networks, which drive mitochondrial DNA-related disorders. Equally significant is the dysregulation of immune response genes in vapers and smokers.”

A genetic predisposition to smoking initiation is associated with an increased risk of e-cig use

In other news, a recent study published on Plos Medicine looked into whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes. The study titled, “Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study,” aimed to determine whether the relationship between vaping and smoking is causal, or whether it exists due to shared factors that influence both behaviours, such as a genetic liability.

Smoking initiation PRS were calculated for 7,859 young adults. A total of 878 (30%) had ever used e-cigarettes at 24 years, and 150 (5%) were regular e-cigarette users at 24 years. The researchers looked for positive associations of similar magnitude between smoking initiation PRS and both smoking initiation and ever e-cigarette use by the age of 24 years, which would show that a genetic predisposition to smoking initiation is associated with an increased risk of e-cig use.

The compiled data did indeed find such an association. “Our results indicate that there may be a shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, externalising disorders in childhood, and risky behaviour more generally. This indicates that there may be a common genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking phenotype.”

 

Source:Vaping Post

Study Links Vaping to Disease-Causing Genetic Changes
Firstunion Dual Heating System HTP “Biheat” Launches at InterTabac, Germany
Firstunion Dual Heating System HTP “Biheat” Launches at InterTabac, Germany
CFU launched the Biheat HTP series at InterTabac in Germany, featuring the world’s first dual-heating system combined with AI control and a 3.42-inch display, enabling multi-dimensional collaborative heating and personalized temperature adjustment, with each stick delivering over 40% more puffs than traditional solutions.
Sep.18
69% of Russians Support Full Ban on E-Cigarette Sales, SuperJob Survey Shows
69% of Russians Support Full Ban on E-Cigarette Sales, SuperJob Survey Shows
According to Gazeta.Ru, a SuperJob poll found that 69% of Russians support President Vladimir Putin’s decision to fully ban vape sales in Russia. Only 7% oppose the ban, while 15% said they are indifferent and 9% were undecided.
Nov.10 by 2FIRSTS.ai
London police crackdown on drug-laced e-cigarettes: Over 2,000 poisoning charges expected in 2024-2025
London police crackdown on drug-laced e-cigarettes: Over 2,000 poisoning charges expected in 2024-2025
London police announced a crackdown on drug-tainted e-cigarettes. The operation stemmed from an incident in the southeast of the capital where e-cigarettes were laced with "cannabis-like products," leading to the hospitalization of a 14-year-old. Data shows that between March 2024 and March 2025, London police received over 2,000 allegations of drug-tainted e-cigarettes. Of the victims in August 2025, 66% were women, a disproportionately high proportion.
Sep.26 by 2FIRSTS.ai
2Firsts to Host Special Session at InterTabac on September 19
2Firsts to Host Special Session at InterTabac on September 19
2Firsts will host a special session at the InterTabac exhibition in Dortmund on September 19, 2025, under the theme “From Change to Opportunity.” As an official media partner, 2Firsts will highlight technology, supply chain, market, and capital opportunities while fostering global dialogue.
Sep.15
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10
2Firsts On-Site at InterTabac: Industry Suppliers Confident About Outlook Despite Stagnant Cigarette Volumes
2Firsts On-Site at InterTabac: Industry Suppliers Confident About Outlook Despite Stagnant Cigarette Volumes
At InterTabac 2025, 2Firsts spoke with traditional tobacco suppliers. Despite stagnant cigarette sales in many regions, they remained optimistic, believing that adapting to market shifts could help them grow in a shrinking sector. Many companies are now moving into emerging categories like nicotine pouches, roll-your-own, and heat-not-burn products, using innovation and infrastructure upgrades to meet changing consumer and regulatory demands.
Sep.22